HIF-1α induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia
- Ying Dai,
- Meifeng Xu(corresponding author),
- Yigang Wang,
- Zeeshan Pasha,
- Tingyu Li,
- Muhammad Ashraf
- University of Cincinnati,
- Chongqing Medical University,
- Center of Excellence in Molecular Biology
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>Hypoxia inducible factor-1α (HIF-1α) is a proangiogenic transcription factor stabilized and activated under hypoxia. It regulates the expression of numerous target genes, including vascular endothelial growth factor (VEGF) and other cytoprotective proteins. In this study, we hypothesized that bone marrow stem cells (BMSCs) secrete growth factors which protect cardiomyocytes via HIF-1α pathway. BMSCs were obtained from transgenic mice overexpressing green fluorescent protein (GFP). The study was carried out in vitro using co-culture of BMSCs with cardiomyocytes. LDH release, MTT uptake, DNA fragmentation and annexin-V positive cells were used as cell injury markers. The level of HIF-1α protein as well as its activated form and VEGF were measured by ELISA. The expression of HIF-1α and VEGF in BMSCs was analyzed by quantitative PCR and cellular localization was determined by immunohistochemistry. LDH release was increased and MTT uptake was decreased after exposure of cardiomyocytes to hypoxia for 30 h, which were prevented by co-culturing cardiomyocytes with BMSCs. Cardiomyocyte apoptosis induced by hypoxia and H<sub>2</sub>O<sub>2</sub> was also reduced by co-culture with BMSCs. VEGF release from BMSCs was significantly increased in parallel with high level of HIF-1α in BMSCs following anoxia or hypoxia in a time-dependent manner. Although no significant up-regulation could be seen in HIF-1α mRNA, HIF-1α protein and its activated form were markedly increased and translocated to the nucleus or peri-nuclear area. The increase and translocation of HIF-1α in BMSCs were completely blocked by 2-methoxyestradiol (2-ME2; 5 μmol), a HIF-1α inhibitor. Moreover, the protection of cardiomyocytes by BMSC and VEGF secretion was abolished by neutralizing HIF-1α antibody in a concentration dependent manner (200-3200 ng/ml). Bone marrow stem cells protect cardiomyocytes by up-regulation of VEGF via activating HIF-1α.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 1036-1044 (9 pages)Journal (Volume, Issue Number)
Journal of molecular and cellular cardiology (Volume 42, Issue 6)Publication milestones
- Published - 06/2007
Publication status
Published - 06/2007
ISSN
0022-2828Publication IDs
- Scopus: 34249688691
- PubMed: 17498737
Publication metrics
Metrics
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
SciVal
FWCI
3.82
SciVal
Author count
6
SciVal
citations
135
SciVal
Paper percentile
97
SciVal
Top percentile
5
PlumX, opens in new tab
Captures
49
Citation count
157
Funding Details
This work was supported by National Institutes of Health grants R37-HL074272, HL087246, HL080686, HL70062 (M. Ashraf), HL083236 (M. Xu) and HL081859 (Y. Wang).
FundersFunding numbers
NIH
R37-HL074272, HL70062, HL080686, HL087246, HL083236
NHLBI
R01HL081859
